Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Blood transfusions increase mortality of hospitalized heart patients

06.10.2004


Heart patients are more than twice as likely to die during their first 30 days of hospitalization if they receive a blood transfusion to treat blood loss or anemia, according to a new analysis by cardiologists at the Duke Clinical Research Institute (DCRI).

Additionally, such patients are more than three times as likely to suffer a heart attack within 30 days, when compared to those who did not receive a transfusion.

These findings -- which emerged after a retrospective analysis of the treatments received by more than 24,000 patients hospitalized with an acute coronary syndrome -- run counter to earlier and smaller observational studies. For this reason, the researchers believe that a large randomized clinical trial needs to be initiated to resolve the issue and provide clear evidence-based guidance on how best to treat these patients. "Until such a trial can be conducted to resolve the differences between our study and past studies, we suggest caution in the routine use of blood transfusion for heart patients who are stable," said Duke cardiologist Sunil Rao, M.D., lead author of a study. For example, Rao said that cardiologists should not automatically order blood transfusions for anemic patients. The study results will be published Oct. 6, 2004, in the Journal of the American Medical Association. "The risks of transfusion remained even after we statistically controlled for other factors, such age, other illnesses and timing of the transfusions."



This issue is an important one, the researchers said, since cardiologists are now more aggressive in the treatment of patients who come to the hospital with symptoms of a heart attack. Physicians will often use clot-busting drugs or angioplasty procedures in an attempt to quickly re-open clogged arteries and save at-risk heart muscle. These treatments, as well as the routine drawing of blood for laboratory tests during hospitalization, can often leave patients with blood loss or anemia, a condition marked by decreased levels of oxygen-carrying red blood cells. "Many physicians, upon learning that their heart patients are anemic, will reflexively order a blood transfusion, believing that the additional red blood cells will deliver more oxygen to the heart and other tissues," Rao said. "However, there is data to suggest that oxygenation of the tissues do not necessarily increase as a result of blood transfusion."

The better understand the effects of transfusion on patient outcomes, the research team pooled the medical data from three large randomized clinical trials involving patients with acute coronary symdromes. Of the combined 24,111 patients, 10 percent (2,401) received at least one blood transfusion during the first 30 days of their hospitalization. The researchers found that in general, the patients receiving transfusions were older and had more additional medical problems.

Since the original clinical trials were not specifically designed to study the effect of transfusion, the researchers used three different statistical approaches in analyzing any associations between transfusions and adverse outcomes. All came to the same conclusions.

Specifically, the researchers found that 8 percent of transfused patients had died after 30 days, compared to 3.08 percent for those who did not receive a transfusion. Heart attacks occurred in 25.16 percent of those receiving additional blood, compared to 8.16 percent for those who did not. "The results of our analysis suggest that physicians should look at the whole patient, and not just the blood count number, when considering whether or not to transfuse someone," Rao said. "If patients appear to be fine, except for an abnormal blood number, it is probably best to hold off on transfusion. The body is constantly replenishing its blood supply, so in these patients it may be best to follow them to see if they can raise their blood counts on their own. If they don’t, then the physician should investigate potential underlying causes why the patient’s body isn’t responding."

According to Rao, the causes underlying the increased incidence of adverse events after transfusion are unclear. Previous studies have shown that transfused blood increases oxygen delivery only in the most severely anemic patients. Also, nitric oxide is essential for delivery of oxygen from the hemoglobin in red blood cells to tissues. However, according to Rao, nitric oxide has a short half-life, so by the time stored blood has been transfused, the essential nitric oxide may have been depleted.

It is also possible, Rao continued, that the transfused blood may stimulate an immune response that can exacerbate already existing coronary artery disease. "All of these factors, taken together, may act to promote ischemia in the heart rather than mitigate it,’ he said.
Rao’s analysis was funded by the DCRI. The three trials from which data was collected were GUSTO (Global Use of Strategies to Open Occluded Coronary Arteries) IIb, PURSUIT (Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy) and PARAGON (Platelet IIb/IIIa Antagonism for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network) B.

Additional Duke members of the team were: James Jollis, M.D., Robert Harrington, M.D., Christopher Granger, M.D., Kristin Newby, M.D., Lauren Linblad, Karen Piper, Jonathan Stamler, M.D. (also a Howard Hughes Medical Institute investigator) and Robert Califf, M.D. Other members of the team were Eric Topol, M.D., Cleveland Clinic; Paul Armstrong, M.D., University of Alberta; and David Moliterno, M.D., University of Kentucky.

Richard Merritt | EurekAlert!
Further information:
http://www.mc.duke.edu

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>